Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
U.S. Government Accountability Office. FDA Laboratories: Magnitude of Benefits Associated With Consolidation Is Questionable. HEHS-96-30. Washington, DC, 1996. https://www.govinfo.gov/app/details/GAOREPORTS-HEHS-96-30.
Health, Education, and Human Services Division, Government Accountability Office. (1996, March 19). GAO/HEHS-96-30 - FDA Laboratories: Magnitude of Benefits Associated With Consolidation Is Questionable. [Government]. U.S. Government Printing Office. https://www.govinfo.gov/app/details/GAOREPORTS-HEHS-96-30
Health, Education, and Human Services Division, Government Accountability Office. GAO/HEHS-96-30 - FDA Laboratories: Magnitude of Benefits Associated With Consolidation Is Questionable. U.S. Government Printing Office, (19 Mar 1996), https://www.govinfo.gov/app/details/GAOREPORTS-HEHS-96-30
Health, Education, and Human Services Division, Government Accountability Office, FDA Laboratories: Magnitude of Benefits Associated With Consolidation Is Questionable, GovInfo, (March 19, 1996), https://www.govinfo.gov/app/details/GAOREPORTS-HEHS-96-30